Koninklijke Philips Analyst Ratings
Koninklijke Philips Analyst Ratings
ResMed Upgraded at JPMorgan; Says GLP-1 Threat Overdone
ResMed Upgraded at RBC Capital Markets Ahead of Q4 Earnings
GE HealthCare Draws Equal Weight Rating at Morgan Stanley on Valuation
Philips Downgraded to Hold at Societe Generale on Diminished Likelihood of 2023 Recovery
Philips Upgraded at Societe Generale; Says Stock More Than Discounts Bad News
Royal Philips Raised to Neutral From Sell by UBS
ResMed downgraded at JPMorgan and RBC despite earnings beat
Koninklijke Philips Cut to Hold From Buy by Societe Generale